Company Overview and News

1
Trump says U.S. will compete with Russia for European gas market

2018-07-16 worldoil
MOSCOW (Bloomberg) -- U.S. President Donald Trump eased his tone about a Russian natural gas pipeline to Germany after a one-on-one meeting with President Vladimir Putin, shifting from the harsh criticism he’d levied in Europe last week.
RDS.B RDS.A UNPPY OMVKY RDSB RDSA UNPRF OMVJF ENGI OMVZY RYDBF BFFAF BFA BASFY RYDAF

1
Trump: US to Compete With Russia for Europe Gas Market

2018-07-16 rigzone
(Bloomberg) -- U.S. President Donald Trump eased his tone about a Russian natural gas pipeline to Germany after a one-on-one meeting with President Vladimir Putin, shifting from the harsh criticism he’d levied in Europe last week.
RDS.B RDS.A UNPPY OMVKY RDSB RDSA UNPRF OMVJF ENGI OMVZY RYDBF BFFAF BFA BASFY RYDAF

0
BASF to donate $7 million toward construction of new UC Berkeley research chemistry facility

2018-07-13 globenewswire
FLORHAM PARK, N.J. and OAKLAND, Calif., July 13, 2018 (GLOBE NEWSWIRE) -- BASF will donate $7 million toward the construction of a new state-of-the-art, interdisciplinary research chemistry facility at the University of California, Berkeley (UC Berkeley). Research conducted in the new “Berkeley Science and Engineering Hub” will converge the expertise of chemists, biologists, engineers, computer scientists, ecologists, social scientists, policy experts, economists, entrepreneurs and industry and civic leaders.
BFFAF BFA BASFY

18
BMW Set to Be First Foreign Automaker to Control China JV - Bloomberg

2018-07-12 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
TM TYT TOYOF DDAIF VLKAF 1114 GM.WS.A GM.WS.B GM.WS.C 7203 BFFAF BFA BASFY GM GM.WSB QCOM

1
Nord Stream 2 Hits Back at Trump's Attack on Russian Gas - Bloomberg

2018-07-12 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
RDS.B RDS.A UNPPY OMVKY RDSB RDSA UNPRF OMVJF ENGI OMVZY RYDBF BFFAF BFA BASFY RYDAF

0
BASF Playing China Matchmaker Should Worry U.S. - Bloomberg

2018-07-12 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
STAN BNPQY ULVR OGZD UNLNF HSB STAB STAC SCBFF STAN BFFAF HSBC.PRA HSBC SYT HBCYF HCS.PRB UL UN UNLYF BNPQF DDAIF HCS SYENF VLKAF 0005 BNPZY 580001 2888 HSEA HSEB BASFY BFA 81JK

0
Merkel lauds China's market opening in trade rebuff to Trump

2018-07-09 malaymail
BERLIN, July 10 — German Chancellor Angela Merkel praised China for opening up to foreign investment, drawing a contrast with trade conflicts burdening both countries’ relations with the US.
BFFAF BFA BASFY

0
Merkel Lauds China's Market Opening in Rebuff to Trump Trade War - Bloomberg

2018-07-09 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
BFFAF BFA BASFY

0
BMW unveils plan to boost production in China

2018-07-09 malaymail
MUNICH, July 9 — BMW AG is increasing manufacturing capacity in China in a move that will help the automaker lower its reliance on imports from a US factory just as trade tensions between the two countries intensify.
BFFAF BFA BASFY

27
As Trump riles Europe on trade, Putin offers more natural gas

2018-06-04 worldoil
Putin will mark 50 years of gas exports to Europe at an event in Vienna on Tuesday. A controversial 9.5 billion-euro ($11 billion) pipeline to feed more supplies from Siberia directly into Germany is progressing despite a U.S. sanctions threat. And Moscow-based Gazprom PJSC last month settled a seven-year-old pricing dispute with the European Union, enabling it to expand its market share.
RDS.B RDS.A UNPPY OMVKY RDSB RDSA UNPRF OMVJF ENGI OMVZY RYDBF BFFAF BFA BASFY RYDAF

6
Bayer to raise $30 billion in share, bond sales for Monsanto

2018-06-04 livemint
London: Bayer AG is planning to raise €6 billion ($7 billion) in a rights offering and €20 billion from bond sales to help fund its $66 billion purchase of Monsanto Corp., an acquisition that received the blessing of US antitrust authorities last week after two years of negotiations.
MON BFFAF BFA BASFY

7
A Quick Overview of the Bayer-Monsanto Merger After DOJ Approval

2018-05-30 zacks
The Justice Department granted antitrust approval on Tuesday for Bayer’s (BAYRY - Free Report) proposed acquisition of Monsanto (MON - Free Report) , after requiring the German giant to divest roughly $9 billion worth of assets and businesses. So let’s dive into a quick overview of everything investors need to know about the deal.
TWX DOW BFFAF BFA BASFY TWC

5
[Press] Gazprom and BASF Discuss Joint Gas Production and Transmission Projects

2018-05-30 oilvoice
A working meeting between Alexey Miller, Chairman of the Gazprom Management Committee, and Martin Brudermueller, Chairman of the Board of Executive Directors of BASF, took place in St. Petersburg today.
BFFAF BFA BASFY

6
Bayer Wins U.S. Nod for Monsanto, Nearing End of Two-Year Quest - Bloomberg

2018-05-29 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
SYENF MON DOW BFFAF BFA BASFY DWDP SYT

7
Diesel is ‘finished’ in Europe amid push for electric cars, EU regulator says

2018-05-28 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
BFFAF BFA BASFY DDAIF

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...